• Jan 1, 2026 books for pharmacovigilance gement. Target Audience: Industry PV teams. Regulatory strategists. Quality assurance professionals. Why it’s valuable: It offers a holistic view of PV’s role within pharmaceutical companies, emphasizing integration with development By Benjamin Steuber
